title: Low bioavailability of rectally administered thalidomide.
authors.affiliation: Malmö University Hospital (MUH), Sweden. tommy.eriksson@apoteket.se
authors.forename: T
authors.initials: T
authors.lastname: Eriksson
authors.forename: R
authors.initials: R
authors.lastname: Wallin
authors.forename: P
authors.initials: P
authors.lastname: Höglund
authors.forename: B
authors.initials: B
authors.lastname: Roth
authors.forename: Z
authors.initials: Z
authors.lastname: Qi
authors.forename: O
authors.initials: O
authors.lastname: Ostraat
authors.forename: S
authors.initials: S
authors.lastname: Björkman
mesh_terms: D000285:Administration, Rectal; D000328:Adult; D000704:Analysis of Variance; D019540:Area Under Curve; D001682:Biological Availability; D018592:Cross-Over Studies; D005782:Gels; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D013488:Suppositories; D013792:Thalidomide / Q000097:blood* / Q000493:pharmacokinetics
chemical_list: D005782:Gels; D007166:Immunosuppressive Agents; D013488:Suppositories; D013792:Thalidomide